QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 adapthealth-narrows-fy2025-sales-guidance-from-3150b-3290b-to-3180b-3260b-vs-3252b-est

Financial OutlookThe Company is updating previous financial guidance for fiscal year 2025, as follows:Net revenue of $3.18 bill...

 adapthealth-closes-disposition-of-certain-infusion-assets-in-wellness-at-home-segment-uses-sale-proceeds-to-pay-down-65m-in-debt

AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-center...

 truist-securities-maintains-buy-on-adapthealth-lowers-price-target-to-13

Truist Securities analyst David Macdonald maintains AdaptHealth (NASDAQ:AHCO) with a Buy and lowers the price target from $1...

 rbc-capital-maintains-outperform-on-adapthealth-lowers-price-target-to-13

RBC Capital analyst Ben Hendrix maintains AdaptHealth (NASDAQ:AHCO) with a Outperform and lowers the price target from $14 t...

 adapthealth-lowers-fy2025-sales-guidance-from-322b-336b-to-318b-332b-vs-327b-est-sees-adjusted-ebitda-of-665m-to-705m-prior-670m-to-710m

Financial OutlookThe Company is updating previous financial guidance for fiscal year 2025 to account for the disposition of cer...

 adapthealth-q1-eps-005-misses-004-estimate-sales-77788m-beat-76477m-estimate

AdaptHealth (NASDAQ:AHCO) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate of $0.04 b...

 baird-maintains-outperform-on-adapthealth-raises-price-target-to-16

Baird analyst Eric Coldwell maintains AdaptHealth (NASDAQ:AHCO) with a Outperform and raises the price target from $14 to $16.

 canaccord-genuity-maintains-buy-on-adapthealth-raises-price-target-to-14

Canaccord Genuity analyst Richard Close maintains AdaptHealth (NASDAQ:AHCO) with a Buy and raises the price target from $13 ...

 rbc-capital-maintains-outperform-on-adapthealth-raises-price-target-to-14

RBC Capital analyst Ben Hendrix maintains AdaptHealth (NASDAQ:AHCO) with a Outperform and raises the price target from $11 t...

 truist-securities-maintains-buy-on-adapthealth-raises-price-target-to-14

Truist Securities analyst David Macdonald maintains AdaptHealth (NASDAQ:AHCO) with a Buy and raises the price target from $1...

 adapthealth-q4-2024-gaap-eps-034-beats-027-estimate-sales-85665m-beat-82919m-estimate

AdaptHealth (NASDAQ:AHCO) reported quarterly earnings of $0.34 per share which beat the analyst consensus estimate of $0.27 by ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION